Brief: 3D Signatures software identifies patients with Alzheimer's disease from cheek swab
21/03/2017 11:07
March 21 (Reuters) - 3D Signatures Inc DXD.V :
* 3D Signatures- clinical study results say based on swab
from a patient's cheek, its proprietary Teloview software
platform can identify Alzheimer's disease
Source text for Eikon: ID:nGNXNQWQKa
Further company coverage: DXD.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Telo Genomics
See all newsBrief: Telo Genomics Announces Positive Results Of Smoldering Multiple Myeloma Proof Of Concept Study
Brief: Telo Genomics Announces Final Assignment Of Patents On Hematological Cancers, Liquid Biopsy & Alzheimer's Disease
Brief: Telo Genomics Announces Multiple Myeloma Collaboration With Mayo Clinic
Brief: 3D Signatures Announces Name Change To Telo Genomics Corp
Brief: 3D Signatures Says Current Board And Executive Management Team Do Not Intend To File For Bankruptcy